VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors

Andrew J Thompson, M H P Verheij, I J P de Esch, S.C.R. Lummis

Research output: Contribution to JournalArticleAcademicpeer-review


The actions of a novel, potent 5-HT₃ receptor ligand, [2-chloro-(4-methylpiperazine-1-yl)quinoxaline (VUF10166)], were examined at heterologously expressed human 5-HT₃A and 5-HT₃AB receptors. VUF10166 displaced [³H]granisetron binding to 5-HT₃A receptors expressed in human embryonic kidney cells with high affinity (K(i) = 0.04 nM) but was less potent at 5-HT₃AB receptors (K(i) = 22 nM). Dissociation of [³H]granisetron in the presence of VUF10166 was best fit with a single time constant (t(1/2) = 53 min) at 5-HT₃A receptors, but with two time constants (t(1/2) = 55 and 2.4 min) at 5-HT₃AB receptors. Electrophysiological studies in oocytes revealed that VUF10166 inhibited 5-HT-induced responses at 5-HT₃A receptors at nanomolar concentrations, but inhibition and recovery were too slow to determine an IC₅₀. At 5-HT₃AB receptors, inhibition and recovery were faster, yielding an IC₅₀ of 40 nM. Cysteine substitutions in the complementary (-), but not the principal (+), face of the 5-HT₃B subunit produced heteromeric receptors in which the actions of VUF10166 resembled those at homomeric receptors. At 5-HT₃A receptors, VUF10166 at higher concentrations also behaved as a partial agonist (EC₅₀ = 5.2 μM; R(max) = 0.24) but did not elicit significant responses at 5-HT₃AB receptors at ≤100 μM. Thus, we propose that VUF10166 binds to the common A+A- site of both receptor types and to a second A+B- modulatory site in the heteromeric receptor. The ability of VUF10166 to distinguish between 5-HT₃A and 5-HT₃AB receptors could help evaluate differences between these receptor types and has potential therapeutic value.

Original languageEnglish
Pages (from-to)350-9
Number of pages10
JournalThe Journal of Pharmacology and Experimental Therapeutics
Issue number2
Publication statusPublished - May 2012


  • Animals
  • Cells, Cultured
  • Female
  • Granisetron
  • HEK293 Cells
  • Humans
  • Isotope Labeling
  • Ligands
  • Mutation
  • Oocytes
  • Piperidines
  • Protein Binding
  • Quinoxalines
  • Receptors, Serotonin, 5-HT3
  • Serotonin 5-HT3 Receptor Agonists
  • Serotonin 5-HT3 Receptor Antagonists
  • Xenopus laevis
  • Journal Article
  • Research Support, Non-U.S. Gov't


Dive into the research topics of 'VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors'. Together they form a unique fingerprint.

Cite this